INTRODUCTION
Development and differentiation are characterized by genetic circuitry or gene regulatory networks (GRNs) that have inherent forward momentum encoded by a number of regulatory motifs (Davidson, 2010) . To self-renew and maintain differentiation potential, stem cells must structure their GRNs so as to arrest or buffer this forward trajectory. Networks at early multipotent stages may bear little relation to those of mature differentiated cells, making comparison between them difficult. Detailed time-series data are useful in this regard (Bruno et al., 2004; , but there is likely substantial asynchrony between individual cells at any given time point. Cells also may undergo lineage commitment through different initial gene expression trajectories (Pina et al., 2012) . Together, these factors can confound attempts to infer network architectures and gain molecular insights into commitment and subsequent lineage specification from averaged gene expression profiles.
Analysis of gene expression in single cells offers a different approach that, in principle, makes use of cellular heterogeneity as a source of variation for establishing gene-gene associations. Recent studies have used all expression data Moignard et al., 2013 Moignard et al., , 2015 or inferred pairwise gene associations using only co-expressing cells (Stå hlberg et al., 2011) . It has been suggested that levels of expression are better accounted for in cells that co-express both genes, and may be obscured by presence/absence effects when all cells are considered (Rusnakova et al., 2013) . We have tried to address this constraint in our exploration of gene expression networks around the erythroid versus myelo-monocytic lineage choice of multipotent hematopoietic progenitor cells. Additionally, we have focused on capturing networks from closely related cells in the vicinity of the commitment boundary, to gain insight into the evolution of GRNs relevant to lineage specification.
The erythro-myeloid bifurcation is an intensively studied paradigm, and both transcription factors (TFs) and regulatory motifs involved in physiological transcriptional programming of these alternative fates have been described (Wolff and Humeniuk, 2013) . Key players include Gata factors, the Ets family protein Pu.1, and C/ebp family members, whose potency has been demonstrated in the experimental reprogramming of blood lineages (Graf and Enver, 2009 ). We used two distinct cell commitment scenarios to obtain high resolution around the early phase of commitment and lineage specification. First, we identified and prospectively isolated cells spontaneously committing to both lineages under culture conditions that maintain self-renewing (SR) cells and lack pro-differentiative cytokines. Second, we used inducible variants of the lineage-affiliated TFs Gata1 and Pu.1 to drive cells into lineage specification, again in the absence of pro-differentiative cytokines. This approach allows timed sampling after instigation of a discrete lineage trigger, and it may provide a more homogeneous molecular entry into commitment and lineage development.
We describe state-distinct networks in multipotent and early lineage-committed cells and, in particular, highlight the existence of lineage-conflicting programs at the emergence of lineage choice. We further identify an axis involved in lineage specification that includes Gata2 and Ddit3, a C/ebp family member previously implicated in stress response (Zinszner et al., 1998) and described as a potential target of erythropoietin signaling in erythro-leukemic cell lines (Coutts et al., 1999) .
RESULTS
We have explored commitment in the non-transformed bone marrow (BM)-derived hematopoietic multipotent cell line FDCPmix. FDCPmix is karyotypically normal, IL-3 dependent, and capable of multilineage differentiation in response to the appropriate environmental cues. Under maintenance culture conditions, SR and lineage-committed cells (erythroid-or myeloid-committed progenitors [ECPs or MCPs] ) co-exist in culture ( Figure 1A ) and can be isolated on the basis of their surface phenotype ( Figure 1B ). SR cells are Kit+Gr1À cells ( Figure 1B ) with proliferative capacity in bulk and clonal cultures (Figures S1A and S1B) and are uniquely able to faithfully reconstitute the cellular heterogeneity observed in maintenance cultures (Figure S1C) . Lineage-committed cells devoid of SR potential are Gr1+ MCPs, with an early myeloid morphology ( Figure S1D ) and no erythroid differentiation capacity ( Figure S1E ), and kitÀGr1À ECPs, with accelerated erythroid differentiation (Figure S1E ) but minimal or no contribution to neutrophil cultures ( Figure S1F ). The transcriptional signatures of SR, MCP, and ECP compartments are readily distinct ( Figure S1G ) and confirm their lineage affiliation (Table S1) .
We next explored cellular heterogeneity within these cell compartments using single-cell multiplex qRT-PCR. The results showed substantial cell-to-cell heterogeneity ( Figure 1C ) and overlap ( Figure 1F ) within and among all three compartments; nevertheless, the compartments may be robustly identified using single and dual-gene classifiers (Table S1 ). The transcriptional heterogeneity observed within individual populations may highlight the capture of multiple contemporaneous molecular programs underlying lineage commitment under self-renewal conditions. Since TFs are potent instigators of lineage determination or reprogramming, we next examined cellular and transcriptional heterogeneity in FDCPmix cells driven to erythroid or myeloid lineages through expression of inducible Gata1 or Pu.1 estrogen receptor fusions, respectively ( Figure S1H ). We analyzed the transcriptional programs of single cells captured at various time points ( Figure S1I ) after induction. In parallel, we studied the temporal dynamics of lineage commitment in this setting and functionally tested their commitment status by evaluating the following: (1) their retention of self-renewal potential, i.e., their capacity to re-initiate maintenance cultures; and (2) their lineage potential in response to various cytokine cues. This experimental design affords a dynamic appreciation of cellular and molecular mechanisms employed in lineage specification.
Activation of Gata1 in SR cells led to phenotypic changes at as early as 4-6 hr ( Figure 1D ), accompanied by the loss of neutrophil potential (at 6 hr) and followed by the loss of SR capacity (at 45 hr) ( Figure 1E ). Enforced Pu.1 activity resulted in the loss of clonogenic SR potential and elicited a myeloid differentiation bias in a more extended time frame (Figures S1J and S1K). Single-cell transcriptional profiling during TF-driven commitment confirmed the lineage identity of the cells obtained, which broadly separated away from the SR state along erythroid (Gata1) and myeloid (Pu.1) axes ( Figure 1F ). The analysis also revealed significant heterogeneity of molecular programs throughout the process of commitment. Gata1-driven cells cooccupied the same transcriptional space as ECP cells and showed a similar extent of cell-to-cell variation. In contrast, Pu.1-driven cells, while similarly heterogeneous to MCPs, appeared to occupy a distinct territory (data not shown). This presumably reflects the neutrophilic status of MCPs and a monocytic bias of Pu.1-ERT-differentiated cells, consistent with prior reports of Pu.1-driven cell fate (Laslo et al., 2006) .
We exploited the heterogeneity of cells at early stages of spontaneous and TF-driven lineage commitment to explore the transcriptional networks controlling lineage specification. Inspection of patterns of expression for individual genes revealed a fraction of cells in which the gene is off, and a fraction of cells expressing the gene to varying levels (on) (Figure 2A ). The on/off status can be described as binary while the distribution of on values represents a continuous component of the data. Thus, for any given gene pair, both binary and continuous relationships are possible; this is exemplified for Gata1 and Epor in Figure 2B . We sought to capture both kinds of information to infer putative transcriptional networks. Methodologically, we used odds ratio (OR) to quantify on/off gene-to-gene associations ( Figure 2C ) and Spearman rank correlation to measure correlations between gene expression levels ( Figure 2D ). We combined gene associations obtained by both methodologies to infer putative regulatory networks characterizing SR states and the different modes of lineage commitment ( Figure 2E ).
At coarse grain, the networks revealed increased connectivity in the lineage-committed compared to the SR state. Also, commitment appeared associated with a higher frequency of negative associations between genes ( Figures 2F and S2A ), including known lineage-determining factors (Table S1 ). While this may be, to some extent, a function of the genes analyzed, it also may reflect mechanistically distinct processes governing acquisition of lineage identity versus exit from self-renewal. Negative associations are less prominent in the full-activation time courses of TF-driven commitment, as the networks capture not only the early processes of lineage specification, but also the later consolidation of the differentiation program. This likely increases the proportion of positive associations between lineage-affiliated genes. In contrast, detailed temporal analysis of Gata1-ERT-driven lineage specification revealed that crossantagonistic associations between lineage determinants peak at 6 hr ( Figure 2G ), coincident with early loss of neutrophil differentiation potential ( Figure 1E ) en route to lineage commitment, suggesting that resolution of lineage conflicts is an early step in acquisition of lineage identity. In this respect, Ddit3 emerges as an interesting candidate in lineage cross-antagonism: it is positively associated with Gata2, both in SR and committed cells ( Figure S2B ), and negatively associated with the neutrophil determinant Cebpa, either directly or through Gata2, in MCPs and at early stages of erythroid lineage commitment ( Figure S2B ; Table S1 ). Since Ddit3 has not previously been tabled as a central regulator of erythro-myeloid lineage specification, we functionally tested its impact in loss-and gain-of-function experiments.
Knockdown of Ddit3 (Figures S3A and S3B) in FDCPmix cells resulted in the loss of erythroid and mixed-lineage colonies, with no change to myelo-monocytic potential ( Figure 3A ). The same loss of erythroid potential in colony-forming assays was observed in stem and progenitor cells (KLS) from mouse BM upon knockdown ( Figure 3B ) and constitutive knockout (Figure 3C ) of Ddit3 expression. The data are compatible with a requirement for Ddit3 in the erythroid lineage, while it is dispensable for the development of the myeloid lineage. The negative association observed between Ddit3 and Cebpa in inferred transcriptional networks from early stages of lineage specification (Figures 2E and S2B; Table S1) suggests that Ddit3 contributes to the erasure of myeloid potential. We tested this in myeloidcommitted granulo-monocytic progenitors (GMPs) by enforcing Ddit3 expression ( Figure S3C ), resulting in a transient re-acquisition of self-renewal potential ( Figure 3D ) and a dramatic change in the nature of the colonies obtained ( Figure 3E ), with the predominance of large GM colonies of immature appearance ( Figure 3F ). Cells in these colonies expressed immature surface markers and were predominantly lineage-negative kit+CD34+CD16/32+, thus presenting an essentially GMP phenotype albeit with variable levels of Sca1 expression; in contrast, cells in control colonies exhibited a differentiated Gr1+Mac1+ phenotype (data not shown). Taken together, the data suggest that ectopic expression of Ddit3 in GMPs blocks lineage progression and transiently re-activates self-renewal capacity.
We used single-cell gene expression profiling of GMPs, either wild-type or transduced with a control vector or a Ddit3-expressing lentivirus, to interrogate the transcriptional program changes imposed by enforced expression of Ddit3 and to inspect its role in remodeling of the transcriptional networks underlying lineage progression and/or identity. Enforcement of Ddit3 changed the expression of two-thirds of genes ( Figures S3D and S3E ) predicted as its neighbors in our inferred transcriptional networks ( Figure S2B ), attesting to the robustness of our inference approach. Principal component analysis (PCA) of the populations of individual wild-type and transduced GMP cells separated Ddit3-expressing cells from controls ( Figure 3G ). This separation is mostly attributable to the increased expression of early erythroid regulators Gata2, Tal1, Zfpm1/Fog1, and Gfi1b and the relative loss of M, GM, and G-CSF receptors (Csf1r, Csf2ra, and Csf3r, respectively) as well as of C/ebp family members ( Figure 3H ). The relative gain in the expression of erythroidaffiliated genes and loss of myeloid Csf receptors and C/ebp family TFs further developed with prolonged expression of Ddit3 in GMPs under differentiation conditions that support multilineage output (Figures S3F and S3G) . These data confirm Ddit3 as a positive regulator of erythroid lineage specification at the expense of myeloid fate, providing an experimental validation of the predictive power of the networks we derived by analyzing the heterogeneity of single cells undergoing lineage specification.
We next asked if the relative gain in importance of erythroidaffiliated regulators in Ddit3-transduced GMPs was associated with a global remodeling of the transcriptional networks underlying GMP lineage identity. Indeed, we observed an overall loss in network connectivity specific to the activity of Ddit3 ( Figure 4A ) Moreover, there was a relative gain in connectivity of Gata2 at the expense of myeloid hubs, as quantified in Figure S4A . For a broader appreciation of the transcriptional changes induced by Ddit3, we performed RNA sequencing (RNA-seq). GMPs transduced with Ddit3 or control vector (CSIem) were cultured for up to 5 days under conditions supportive of multilineage output. Similarly to cells obtained from colony-forming assays, Ddit3-transduced cells retained a GMP-like phenotype, while control cells acquired differentiated myeloid surface markers ( Figure S4B ). The global transcriptional profiles of cells with enforced expression of Ddit3 ( Figure S4C ) were clearly distinct from control-transduced and wild-type GMPs. Gene set enrichment analysis (GSEA) showed that Ddit3 expression is associated with global loss of GMP programs and concomitant upregulation of Meg-E-affiliated signatures ( Figure 4B ). Interestingly, signatures representative of pre-GM cells, the developmental precursors of GMPs ( Figure 4C ), also were upregulated ( Figure 4B ). These data suggest that Ddit3 acts through the development or stabilization of a more primitive precursor with inherent Meg-E potential ( Figure 4C ). Analysis of the networks derived from wild-type GMPs ( Figure S4D ) as well as Ddit3-transduced cells exposed to conditions supportive of multilineage output for 2 days ( Figure 4A ) revealed increased importance of specific erythroid versus myeloid regulatory nodes.
Given the association of Gata2 and Ddit3 seen in our network analysis of lineage commitment ( Figure 2E ) and the increase in activity of Gata2 as a hub in Ddit3-transduced GMPs ( Figure 4D ), we explored the behavior of Gata2 target genes, previously identified by chromatin immunoprecipitation sequencing (ChIP-seq) in FDCPmix , in response to Ddit3 expression. GSEA on the RNA-seq data from Ddit3 and control vector-transduced cells provided evidence for a coincidence of Gata2 and Ddit3-driven gene expression programs ( Figure 4E ). These data position Ddit3 in an erythroid transcriptional network nucleated by Gata2. To further explore the Ddit3-Gata2 axis in lineage specification, we focused on gene expression programs resident in those single cells that co-expressed the two genes, and derived networks from multipotent and lineage-committed compartments (Table S1 ). Within the ECP compartment, this analysis revealed the following: (1) an association between the two genes that was not seen when cells were used irrespective of Ddit3/ Gata2 status, and (2) the involvement of both these genes in anti-correlations with myeloid-affiliated regulators. A similar picture now also emerges in multipotent cells, highlighting the gains in network information obtainable from interrogating single cells selected on the basis of specific co-expression patterns.
DISCUSSION
Our analysis of cells in the vicinity of commitment highlights the existence of lineage-conflicting programs at the emergence of lineage choice, and it identifies the importance of a Ddit3-Gata2 axis in this process. In revealing this association, it was instrumental that our network inference approach acknowledged and took account of both binary and continuous components of single-cell gene expression. As such, we captured both on/off relationships and the associations seen between distributions of on expression levels in co-expressing cells. Furthermore, having established potentially interesting associations, we zoomed in on single cells where the associations were present to refine their specific network identity. In the case of Ddit3-Gata2, this supported the importance of cross-antagonistic interactions in lineage decisions. While in principle this approach can be applied to any gene-gene interaction in an unsupervised manner, it would require profiling of considerably higher numbers of individual cells to ensure statistical robustness and systematically explore all possible interactions.
To validate our inferred networks, we elected to experimentally test the predicted role of Ddit3 in erythroid lineage specification. Functional experiments revealed an early erythroid effect from Ddit3 loss of function produced by knockdown or genetic knockout. However, we note that the constitutive Ddit3 knockout mice used in this study did not display any discernible erythroid defect (C.F., unpublished data). Thus, lineage-determining networks may be robust to Ddit3 deletion or constitutive deletion may be compensated during development. Forced Ddit3 expression does promote erythroid programming, highlighting a potential role for the Ddit3 node in early development of the erythroid lineage. Previous reports of Ddit3 function in late differentiation of erythro-leukemic cells (Coutts et al., 1999) are compatible, albeit distinct, from our proposed role in erythroid specification. Interestingly, our inspection of CFU-e potential in mouse BM stem and erythroid progenitor compartments upon Ddit3 ablation did not reveal a late erythroid defect (C.F., unpublished data).
The capacity of TFs to re-program cells has been used as a test of their lineage-determining capacity. In the case of Gata1, its introduction into GMPs results in the expression of erythroid potential with the appearance of large blast-like multipotential colonies in vitro (Heyworth et al., 2002) . Ddit3 likewise is able to confer erythroid potential on GMPs. Molecular analysis suggests that Ddit3-enforced expression in GMPs leads to expression of erythroid-affiliated genes and an overall transcriptional state similar to that of pre-GM, the precursors of GMPs. One may presume that since pre-GM cells lie upstream of GMPs their transcriptional programs should have diverged less from multipotent cells that retain both GM and E potential. This would explain the E signatures seen in Ddit3-expressing GMPs. By which cellular mechanism does Ddit3 effect these changes? One possibility is that rare pre-GMs exist within prospectively isolated GMP populations and that these are preferentially selected for by Ddit3. This seems unlikely, given the kinetics of the changes in cells and gene expression observed. Alternatively, Ddit3 may regulate a subset of the erythroid program that is simply overlaid on the existing GMP program, resulting in a mixed-lineage program that is reminiscent of pre-GM cells. In such a model, Ddit3 effects a pre-GM state from GMPs, recapitulating its physiological role in lineage programming. Recently, Nerlov and colleagues have suggested that high levels of erythropoietin (EPO) may have instructive effects on lineage specification in vivo (Grover et al., 2014) , and interestingly Ddit3 has been suggested as a target of EPO signaling in erythro-leukemic cells (Coutts et al., 1999) . The strong network association observed between Ddit3 and Gata2 may indicate that Ddit3 acts on an early erythroid signature primed by Gata2 in cells of mixed-lineage potential and present in the pre-GM state. Elements of this signature may be required for erythroid lineage progression and, thus, explain the erythroid defect observed upon Ddit3 loss of function.
It is interesting to speculate as to the existence of cross-antagonistic interactions between Gata2-centered networks and C/ebp-driven myeloid programs putatively effected through Ddit3. Ddit3 heterodimerizes with C/ebp family members to form complexes that cannot bind DNA, thus blocking activation of C/ebp-driven programs, a mechanism that has been described to block differentiation in mesenchymal lineages (Han et al., 2013; Shirakawa et al., 2006) . A combination of Ddit3 structure-function mutant studies and direct investigation of Gata2 and C/ebp DNA binding in Ddit3-expressing GMPs will contribute to clarifying dislodgement of C/ebp complexes from their target genes as a putative mechanism of GMP lineage remodeling. 
Cell Culture and Lentiviral Transductions
FDCPmix culture conditions, lentiviral transductions with Gata1-ERT and Pu.1-ERT constructs, and tamoxifen activation were performed as described previously . Lentiviral transductions of FDCPmix cells with Ddit3-small hairpin RNA (shRNA) were performed under maintenance culture conditions; transductions of primary BM cells were performed in serum-free expansion medium (SFEM) (STEMCELL Technologies) supplemented with mouse stem cell factor (SCF) and Flt3L (50 ng/ml). GFP + cells were sorted after 2 days for downstream assays. In some experiments, GFP + GMPs were cultured for up to 5 days in Iscove's modified Dulbecco's medium (IMDM) + 10% fetal calf serum (FCS) supplemented with mouse SCF (50 ng/ml), mouse IL-3 and IL-6 (10 ng/ml), and human recombinant erythropoietin (EPREX, 10 U/ml). Colony-forming cell (CFC) assays used M3234 supplemented with rat SCF (100 ng/ml); mouse IL-3 (0.01 ng/ml) and EPREX (10 U/ml) (FDCPmix); and M3434 or M3234 supplemented with mouse SCF (100 ng/ml), mouse IL-3, IL-11, GM-CSF, and Tpo (10 ng/ml), and EPREX (10 U/ml). All mouse cytokines were from PeproTech and CFC media were from STEMCELL Technologies. 
Single-Cell qRT-PCR

Classification and Network Inference
Single-cell gene expression data were linearly transformed as described previously . Logistic regression linear classifiers were used to infer the best predictor genes in the separation between two cell populations . Single-cell transcriptional networks were inferred by calculating significant pairwise associations using both continuous (Spearman rank correlations) and binary (OR) components of linearly transformed expression data. Spearman rank correlations were calculated between all pairs of genes co-expressed by a minimum of ten cells in a given population. Correlation coefficients >0.4 with p < 0.01 were considered to be significant. OR and respective 95% confidence intervals (CIs) were calculated based on presence/absence patterns of expression for all pairs of genes in a given population. Significant positive and negative associations were called when Lower95CI > 1 and Upper95CI < 1, respectively. Network representations of significant pairwise associations in both methods were produced using Cytoscape (Smoot et al., 2011) Additional methods are described in the Supplemental Experimental Procedures.
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SUPPLEMENTARY METHODS
Mice
B6.129S-Ddit3tm1Dron/J (Ddit3 KO) mice (Marciniak et al., 2004 ) (Jackson Laboratories) and C57BL/6 mice were maintained in the John Radcliffe Hospital (Oxford) and CR-UK London Research Institute animal facilities in accordance with Home Office regulations.
Flow cytometry
KLS and GMP cells were isolated from mouse BM essentially as described (Akashi et al., 2000) , using pre-enrichment on magnetic columns (Miltenyi Biotech) with either Antibodies used are listed below. 
Supplementary Methods
Lentiviral constructs
Full-length mouse Ddit3 and Ddit3-C mutant with N-terminal FLAG tags and engineered BamHI flanking restriction sites were PCR-cloned into T-easy vector (Promega) and subcloned into the BamHI site of CSIEm (pHR-SIN-CSGW-iresEmGFP), as described . All cloning primer sequences are available upon request. Ddit3-shRNA (target sequence:
AAGAGCAAGGAAGAACTAGGAAA; sense oligo: TGAGCAAGGAAGAACTAGGAAAGGGATCCTTTCCTAGTTCTTCCTTCGTCT TTTTTC; antisense oligo:
TCGAGAAAAAAGACGAAGGAAGAACTAGGAAAGGATCCCTTTCCTAGTT CTTCCTTGCTCA) was cloned into the HpaI and XhoI sites of pLentilox 3.7, also as described .
Single-cell quantitative RT-PCR
The Taqman probes used in this study are listed below. Table 2 : Taqman probes used in this study (refers to Experimental Procedures)
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Gene
Assay number
Atp5a1 Mm00431960_m1
Hprt1 Mm00446968_m1
Eomes Mm01351985_m1 Epor Mm00438760_m1
Fcgr3 Mm00438882_m1
Gata1 Mm00484678_m1
Gata2
Mm00492300_m1
Gfi1 Mm00515855_m1
Gfi1b Mm00492319_m1
Jun Mm00495062_s1 Kit Mm00445212_m1
Klf2 Mm01244979_g1
Lmo4 Mm00495373_m1
Ly6a Mm00726565_s1
Lyl1 Mm00493219_m1
Meis1 Mm00487664_m1
Mpl Mm00440310_m1
Mpo Mm00447886_m1
Myc Mm00487803_m1
Nr4a2 Mm00443060_m1
Sfpi1 Mm00488140_m1 Tal1 Mm00441665_m1
Zfpm1 Mm00494336_m1
Note: Control gene expression assays are highlighted in gray.
Microarray analysis and RNA-sequencing
RNA was prepared from Trizol (Life Technologies) lysates. Microarray analysis was performed on an Agilent platform, as described . Differentials between any 2 compartments were calculated using LIMMA (Smyth, 2004) ;
hierarchical clustering was performed in Genesis. For RNA sequencing, cDNA was prepared using Clontech SMARTer ultra-low input RNA kit for Illumina sequencing kit with sonication in a Covaris sonicator. 15ng cDNA were used for library preparation, using individual NEB reagents and NEB Next multiplex oligos for (Trapnell et al., 2012) . Only protein-coding genes were considered and expression values from individual isoforms were averaged. Gene set enrichment analysis (Subramanian et al., 2005) used the data for CSIEm D2 and Ddit3 D2 as phenotype-relevant datasets, and pre-MegE, CFUe, pre-GM and GMP gene signatures (calculated as 4-fold enrichments over the global average) as well as Gata2 ChIP targets in FDCPmix multipotential cells as background datasets . 
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